A new study finds a genetic switch in stem cells that is turned off in progenitor cells leading to loss in self renewal. This can be used to treat diseases.
- Scientists find switch that harnesses the power of cord blood.
- The switch increases the amount of stem cells.
- This can be used in the treatment of blood cancer patients
Use of Stem Cell Transplant in Blood Cancer Patients
- Stem cell transplant will aid in providing normal blood cells for the cancer patients and aid in sustaining life.
- The newly transplanted stem cells will host better immune cells against the cancer cells, this is called graft-versus-cancer cells.
- Bone marrow stem cell transplant
- Peripheral blood stem cell transplant.
- Cord blood stem cell transplant.
Dr. John Dick, principal investigator of the study on stem cells says “About 40,000 people receive stem cell transplants each year, but that represents only about one-third of the patients who require this therapy. That’s why there is a big push in research to explore cord blood as a source because it is readily available and increases the opportunity to find tissue matches. The key is to expand stem cells from cord blood to make many more samples available to meet this need. And we’re making progress.”
The drawback in using stem cells from cord blood is that very few stem cells are available. However, the current study by Dr. Dick and colleagues hopes to harness the power of the cord blood in providing stem cells.
First Discovery Of Stem Cells
Dr. John Dick is a senior scientist at the Princess Margaret Cancer Centre. Two scientists, late Dr. Ernest McCulloch and Dr. James Till discovered the first stem cell in 1961. Their discovery has led to a separate branch of biology that deals with stem cell research, in lieu of the huge potential in medical research.
In 2011 Dr. Dick and colleagues isolated stem cells in the purest form that could
- Give rise to entire range of blood cells
- Opened doorways to tapping into the potential of stem cells in treating diseases.
When Dr. Dick and colleagues studied the mechanism of transformation they found that microRNA- mi125a formed a genetic switch that was turned off in progenitor cells. This resulted in stem cells losing their self- renewal property.
This genetic switch provides a key link to discovering the huge potential of stem cells in the treatment of diseases.
Dr. Dick says “Our work shows that if we artificially throw the switch on in those downstream cells, we can endow them with stemness and they basically become stem cells and can be maintained over the long term”.
Significance of the Study
- The study highlights the presence of a genetic switch that is turned off in the progenitors of stem cells.
- Provides hope for treatment of serious illnesses like blood cancer. Every 4 minutes one person is diagnosed with blood cancer every year.
- Why are Stem Cell Transplants Used as Cancer Treatment? - (http://www.cancer.org/treatment/treatmentsandsideeffects/treatmenttypes/bonemarrowandperipheralblood-stemcelltransplant/stem-cell-transplant-why-stem-cell-trans-used)
- Leukemia Statistics - (http://www.allbloodcancers.org/statistics)